Trulance (plecanatide) / Bausch Health 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   40 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trulance (plecanatide) / Bausch Health
NCT05151328: Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation

Completed
3
648
RoW
Plecanatide, Placebo
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Functional Constipation
10/23
10/23
NCT03596905: Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)

Recruiting
2
210
US
Plecanatide, Trulance, Matching placebo, No other names
Bausch Health Americas, Inc.
Irritable Bowel Syndrome With Constipation
12/23
12/23
NCT05107219: GCC Agonist Signal in the Small Intestine

Recruiting
1
43
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Esophagogastroduodenoscopy, EGD, Linaclotide, [9-L-tyrosine]heat-stable enterotoxin (Escherichia coli)-(6-19)-peptide, Linzess, MD-1100, Plecanatide, Trulance
National Cancer Institute (NCI)
Barrett Esophagus, Gastroesophageal Reflux Disease, Malignant Digestive System Neoplasm
02/25
02/25

Download Options